The totality of evidence approach in the development of AVT02 (adalimumab), a biosimilar to Humira
Article in Therapeutic Advances in Chronic Disease (January 2024)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Article in Therapeutic Advances in Chronic Disease (January 2024)
Article in Pure and Applied Chemistry (January 2024)
Article in Journal of Pharmaceutical and Biomedical Analysis (June 2023)